Literature DB >> 8940257

T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release.

F Gantner1, M Leist, S Küsters, K Vogt, H D Volk, G Tiegs.   

Abstract

Polyclonal T cell stimulation in humans leads to a cytokine burst syndrome that may result in organ failure or lethality. Mechanisms of such cytokine-dependent morbidity can be studied in mice challenged with the T cell mitogen concanavalin A (Con A). In this model tumor necrosis factor (TNF)-dependent toxicity is characterized by a relatively selective liver failure. We examined here whether a crosstalk between liver macrophages and lymphocytes may be the underlying cause for the overshooting TNF response. Lymphocytes from lymph nodes, thymus, or the spleen were cocultured with Kupffer cells and stimulated with the polyclonal T cell stimuli Con A, anti-CD3 mAb, or staphylococcal enterotoxin B. We observed a rapid and synergistically augmented release of TNF, and also of IL-1, IL-2, IL-4, IL-6, and IFN-gamma, compared to stimulation of the individual cell types alone. This dramatically upregulated cytokine response did not require direct cell contact, but was mediated by a soluble factor. In order to find out whether TNF upregulation would require additional cell types in the liver, we used cocultures of T cells and a macrophage cell line and confirmed our previous results. In this model system an increase in TNF mRNA was observed in macrophages, but not in T cells. We conclude that the T cell-macrophage crosstalk following polyclonal T cell stimulation may be responsible for an overshooting TNF release from macrophages. This mechanism finally may lead to organ damage such as liver injury upon Con A injection into mice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940257     DOI: 10.1006/excr.1996.0351

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  3-Aminobenzamide Prevents Concanavalin A-Induced Acute Hepatitis by an Anti-inflammatory and Anti-oxidative Mechanism.

Authors:  Joram Wardi; Orna Ernst; Anna Lilja; Hussein Aeed; Sebastián Katz; Idan Ben-Nachum; Iris Ben-Dror; Dolev Katz; Olga Bernadsky; Rajendar Kandhikonda; Yona Avni; Iain D C Fraser; Roy Weinstain; Alexander Biro; Tsaffrir Zor
Journal:  Dig Dis Sci       Date:  2018-09-08       Impact factor: 3.199

2.  Depletion of hepatic glutathione prevents death receptor-dependent apoptotic and necrotic liver injury in mice.

Authors:  H Hentze; F Gantner; S A Kolb; A Wendel
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

3.  2,3,7,8-TCDD enhances the sensitivity of mice to concanavalin A immune-mediated liver injury.

Authors:  Aaron M Fullerton; Robert A Roth; Patricia E Ganey
Journal:  Toxicol Appl Pharmacol       Date:  2012-11-16       Impact factor: 4.219

4.  Pseudomonas aeruginosa exoenzyme S induces transcriptional expression of proinflammatory cytokines and chemokines.

Authors:  S Epelman; T F Bruno; G G Neely; D E Woods; C H Mody
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

5.  Inhibition of Fas/FasL mRNA expression and TNF-alpha release in concanavalin A-induced liver injury in mice by bicyclol.

Authors:  Min Li; Geng-Tao Liu
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

6.  Interferon-beta reduces the mouse liver fibrosis induced by repeated administration of concanavalin A via the direct and indirect effects.

Authors:  Junichi Tanabe; Akiko Izawa; Natsumi Takemi; Yasushi Miyauchi; Yuichi Torii; Hiromi Tsuchiyama; Tomohiko Suzuki; Saburo Sone; Kazuki Ando
Journal:  Immunology       Date:  2007-07-20       Impact factor: 7.397

7.  Metabolomics in toxicology and preclinical research.

Authors:  Tzutzuy Ramirez; Mardas Daneshian; Hennicke Kamp; Frederic Y Bois; Malcolm R Clench; Muireann Coen; Beth Donley; Steven M Fischer; Drew R Ekman; Eric Fabian; Claude Guillou; Joachim Heuer; Helena T Hogberg; Harald Jungnickel; Hector C Keun; Gerhard Krennrich; Eckart Krupp; Andreas Luch; Fozia Noor; Erik Peter; Bjoern Riefke; Mark Seymour; Nigel Skinner; Lena Smirnova; Elwin Verheij; Silvia Wagner; Thomas Hartung; Bennard van Ravenzwaay; Marcel Leist
Journal:  ALTEX       Date:  2013       Impact factor: 6.043

8.  Pretreatment with TCDD exacerbates liver injury from Concanavalin A: critical role for NK cells.

Authors:  Aaron M Fullerton; Robert A Roth; Patricia E Ganey
Journal:  Toxicol Sci       Date:  2013-08-22       Impact factor: 4.849

Review 9.  State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.

Authors:  Natalie Alépée; Anthony Bahinski; Mardas Daneshian; Bart De Wever; Ellen Fritsche; Alan Goldberg; Jan Hansmann; Thomas Hartung; John Haycock; Helena Hogberg; Lisa Hoelting; Jens M Kelm; Suzanne Kadereit; Emily McVey; Robert Landsiedel; Marcel Leist; Marc Lübberstedt; Fozia Noor; Christian Pellevoisin; Dirk Petersohn; Uwe Pfannenbecker; Kerstin Reisinger; Tzutzuy Ramirez; Barbara Rothen-Rutishauser; Monika Schäfer-Korting; Katrin Zeilinger; Marie-Gabriele Zurich
Journal:  ALTEX       Date:  2014-07-14       Impact factor: 6.043

10.  Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis.

Authors:  Y Kaneko; M Harada; T Kawano; M Yamashita; Y Shibata; F Gejyo; T Nakayama; M Taniguchi
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.